Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC

Clinical trial NCT02343952 · COMPLETED

Trial details

NCT number: NCT02343952
Sponsor: Nasser Hanna, M.D.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2015-03-09
Primary completion: 2020-08-10
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.